Glycoprotein News and Research

RSS
New antiviral repurposing study finds peptides that could prevent SARS-CoV-2-ACE2 binding

New antiviral repurposing study finds peptides that could prevent SARS-CoV-2-ACE2 binding

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Researchers map genetic changes that may have facilitated SARS-CoV-2’s jump from bats to humans

Researchers map genetic changes that may have facilitated SARS-CoV-2’s jump from bats to humans

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

Structure of SARS-CoV-2 cytoplasmic tail uncovered

Structure of SARS-CoV-2 cytoplasmic tail uncovered

Effect of mutations in the South African SARS-CoV-2 variant on transmission and neutralization

Effect of mutations in the South African SARS-CoV-2 variant on transmission and neutralization

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Antibody recognition of linear SARS-CoV-2 epitopes preserved in mutated B.1.1.7 strain

Antibody recognition of linear SARS-CoV-2 epitopes preserved in mutated B.1.1.7 strain

Study shows P681H mutation is becoming globally prevalent among SARS-CoV-2 sequences

Study shows P681H mutation is becoming globally prevalent among SARS-CoV-2 sequences

Naturally selected mutations of SARS-CoV-2 easily duplicated in vitro

Naturally selected mutations of SARS-CoV-2 easily duplicated in vitro

High-affinity SARS-CoV-2 RBD drives mutation spread, forms basis of new COVID-19 inhibitor

High-affinity SARS-CoV-2 RBD drives mutation spread, forms basis of new COVID-19 inhibitor

Antibodies and inflammatory markers are pervasive in colostrum of SARS-CoV-2 infected women

Antibodies and inflammatory markers are pervasive in colostrum of SARS-CoV-2 infected women

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

FDA approves first oral drug for treating adult patients with advanced prostate cancer

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread

SARS-CoV-2 spike deletion ΔH69/ΔV70 shows repeated emergence and spread